Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of switching from omeprazole to pantoprazole on clopidogrel platelet inhibition
NL-OMON32694Phase 4Active, not recruiting
- Sponsor
- Atrium Medisch Centrum Parkstad
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of pantoprazole, omeprazole and clopidogrel in cardiac morbidity and None (2 arms), sponsored by Atrium Medisch Centrum Parkstad. Primary endpoints: Platelet reactivity index and Inhibition of platelet aggregation. Started May 2010; status: active, not recruiting.
02
Drugs
pantoprazoleomeprazoleclopidogrel
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on NL-OMON32694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32694.